The case of Fox Varian, who was awarded $2 million in damages after suing the doctors who facilitated her gender transition while she was a minor, reopens the debate about the lack of rigor in dysphoria diagnoses and the irreversibility of treatments in adolescents.

This court ruling highlights the negligence of doctors who ignored pre-existing conditions such as autism or anxiety. It also reinforces the need for a paradigm shift in medical protocols: scientific evidence and bioethical prudence must prevail in the face of the growing number of people who detransition after undergoing premature interventions.

The Varian Case

Fox Varian, 22, sued the doctors who performed her gender reassignment surgery when she was a minor, alleging negligence. After winning the case, she received a $2 million settlement.

When the young woman was only 16 years old, and despite being a minor, psychologist Kenneth Einhorn authorized the transition and Dr. Simon Chin performed the surgery in which he removed her breasts.

During the trial, held in New York State, Varian’s lawyers argued that the psychologist and surgeon failed to follow the necessary protocols to save her from trauma and surgery. They also stated that it was the psychologist who proposed the idea of ​​transitioning the young woman after diagnosing her with gender dysphoria.

Varian’s mother has stated that she felt intimidated by the psychologist into authorizing her daughter’s surgery because he told her that otherwise she would commit suicide.

The lawyers also argued that other mental health issues such as depression, anxiety, social phobia, and autism were not taken into account before deciding whether to perform the operation.

Furthermore, the doctor who performed the double mastectomy only met briefly with the young woman twice before the surgery. Three years after the operation, Fox Varian detransitioned.

Background

As we have previously published in our Observatory, in 2022 we already warned of the growing number of transgender people who regretted undergoing gender transition treatments.

Cases like that of Keira Bell, who sued the hospital that prescribed her hormone blockers at the age of 16 for failing to objectively inform her of the potential consequences of this treatment. Or the case of a repentant transgender person who exposed the lies of gender ideology.

As an example of the growing trend opposing the widespread adoption of gender transition procedures, the case of the British National Health Service (NHS) should be mentioned. In 2024, it announced that it would stop prescribing puberty blockers in its hospitals to minors wishing to undergo gender transition.

New Trends in the United States

Recently, in February 2026, both the American Medical Association (AMA) and the American Society of Plastic Surgeons (ASPS) expressed doubts about the efficacy and appropriateness of gender transition treatments. Based on the accumulating clinical results, they propose delaying related surgeries until at least age 19.

In this regard, the American Society of Plastic Surgeons warns about the lack of a positive risk-benefit balance in these interventions, specifically when analyzing the long-term consequences.

The studies that support the suitability of these interventions, now questioned, have been denounced for offering serious limitations in their quality, consistency and patient follow-up, which is fundamental for the correct assessment of long-term side effects.

Countries such as Sweden, Norway, Finland, France, England, the United States, and Australia have long warned of a need to modify the application of the so-called Dutch Protocol in the treatment of people with gender dysphoria.

Bioethical assessment

There are already many court rulings that condemn health professionals and related entities to compensate patients who have reported not having been correctly diagnosed and properly informed about the consequences of gender reassignment therapies, suffering their consequences.

The surgical procedures performed for this purpose and hormone treatments have numerous physical and psychological side effects that worsen the quality of life of patients who undergo them.

Intervention in adolescents, as in the case at hand, presents greater risks, associated with hormonal blockers and their consequences on their normal physical and mental development.

Many of the countries that began applying these therapies more than 20 years ago have drastically modified their protocols, limiting access to hormone-blocking treatments and pharmacological and surgical reassignment.

In a previous report, we already showed evidence of how counterproductive pharmacological and surgical gender transition interventions can be in patients with dysphoria, reinforcing the need to provide psychological or psychiatric treatments to those affected.

Many of the laws that regulate these interventions, such as the Spanish one, continue to propose exactly the opposite of what the most recent studies show.

They warn of the destructive effects of these interventions and their limited ability to address the suicidal tendencies of many of those affected.

As a recent study shows, they require psychological and psychiatric treatments, which are not provided to them in many cases.

On the contrary, gender transition is being promoted through pharmacological or surgical interventions.

If appropriate psychological or psychiatric interventions have been previously applied, these operations are not shown to be effective in reducing suicide rates.

However, the administration of treatments with hormonal blockers or surgical interventions presents numerous side effects and complications that contribute to worsening the quality of life of these patients.

The accumulated scientific evidence on these interventions should promote a paradigm shift in intervention protocols in these cases, not the accumulation of court rulings filed by those who have suffered their negative consequences, which are irreversible in many cases.

Julio Tudela and Ester Bosch

Bioethics Observatory – Institute of Life Sciences

Catholic University of Valencia

Share This Story, Choose Your Platform!